Open Access
BIO Web Conf.
Volume 86, 2024
International Conference on Recent Trends in Biomedical Sciences (RTBS-2023)
Article Number 01046
Number of page(s) 13
Published online 12 January 2024
  • Gomes AR; Nagaraju V. High-performance liquid chromatographic separation and determination of the process-related impurities of mebendazole, fenbendazole, and albendazole in bulk drugs. J. Pharm. Biomed Anal. 2001 26, 919–27. [CrossRef] [Google Scholar]
  • Bala I, Verma S, Singh B. Determination of acceptable residual limit by using newly developed and validated RP-HPLC method for citalopram hydrobromide residues that swabbed from surfaces of pharmaceutical manufacturing equipment. International Journal of Drug Delivery Technology. 2019;9(1):10-4. [CrossRef] [Google Scholar]
  • Kowalska M; Woźniak M; Kijek M; Mitrosz P; Szakiel J. Turek P. Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product. Sci. Reports. 2022, 12, 1-9. [Google Scholar]
  • Khanji Mohd; Kawas G. Quantitative determination of albendazole forced degradation percentages by densitometric thin layer chromatographic method. Res. J. Pharm. and Tech. 2020, 13, 2207-2213. [CrossRef] [Google Scholar]
  • Fletouris DJ; Botsoglou NA. Determination of the marker residue of albendazole in milk using ion-pair liquid chromatography and fluorescence detection. Anal Chim Acta. 1997, 345, 111–9. [CrossRef] [Google Scholar]
  • Bhavya B.; Nagaraju P. Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Albendazole and Ivermectin in Pharmaceutical Dosage Form. Asian J. Pharm. Anal. 2017, 7: 6-14. [CrossRef] [Google Scholar]
  • Pimpale AD, Pethe AM, Kakde RB, Kakde IR. A Validated Reversed-phase High-Performance Liquid Chromatography Analytical Method for the Analysis of Methylcobalamin in Bulk Drugs and Dosage Formulation. International Journal of Pharmaceutical Quality Assurance. 2022;13(3):320-323. [CrossRef] [Google Scholar]
  • Kumari N, Singh B. Quality By Design: A systematic approach for the development of analytical method validation., J. of drug. del. and therapeutics. 2019, 9, 1006-1012. [Google Scholar]
  • Bhargava D, Deshpande A, Thomas S, Sharma Y, Khare P, Sahu SK, Dubey S, Pandey A, Sreekumar K. High performance liquid chromatography determination of dexamethasone in plasma to evaluate its systemic absorption following intra-space pterygomandibular injection of twin-mix (mixture of 2% lignocaine with 1: 200,000 epinephrine and 4 mg dexamethasone): randomized control trial. Oral and maxillofacial surgery. 2016, 20, 259-64. [CrossRef] [PubMed] [Google Scholar]
  • Elek Ferencz; Éva-Katalin Kelemen. Computer-assisted UHPLC method development and optimization for the determination of albendazole and its related substances, J. of Pharm. and Biomed. Anal, 2021, 5, 203. [Google Scholar]
  • Papp LA; Krizbai S; Dobó M; Hancu G; Szabó ZI; Tóth G. Determination of Chiral Impurity of Naproxen in Different Pharmaceutical Formulations Using Polysaccharide-Based Stationary Phases in Reversed- Phased Mode. Molecules. 2022, 27, 2986. [Google Scholar]
  • Li L; Xing DX; Li QR; Xiao Y. Determination of albendazole and metabolites in silkworm Bombyx mori hemolymph by ultrafast liquid chromatography-tandem triple quadrupole mass spectrometry. PLoS ONE. 2014, 9, 1-11. [Google Scholar]
  • Kitzman D; Cheng KJ; Fleckenstein L. HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. J Pharm Biomed Anal. 2002, 30, 801–13. [CrossRef] [Google Scholar]
  • Tomar B; Sharma A. Development and Validation of the Analytical method for the estimation of a combination of 5-fluorouracil and Imiquimod by RP-HPLC. Res. J. of Pharm. and Tech. 2021. 14, 3313-8. [Google Scholar]
  • Nageswara Rao R.; Nagaraju V. An overview of the recent trends in the development of HPLC methods for determination of impurities in drugs, J. of Pharm and Biomed. Anal. 2003, 33, 335-377 [CrossRef] [Google Scholar]
  • Kalal DJ; Redasani VK. Stability-indicating RP-HPLC method development and validation for estimation of Mupirocin calcium in bulk and pharmaceutical formulation. Futur J Pharm Sci. 2022, 1-10 [Google Scholar]
  • Armando J; Ardila, Roberto B; de Alvarenga Jr. Design of experiments applied to stress testing of pharmaceutical products: A case study of Albendazole, Eur. J. of Pharm. Sci. 2021, 165, 980-991. [Google Scholar]
  • Dina A; Ahmed; Omar Aziz A; Soheir A. Weshahy, Stability indicating the determination of Albendazole in bulk drug and pharmaceutical dosage form by chromatographic and spectrophotometric methods, Fut. J. of pharm. Sci. 2018, 4, 161-165 [Google Scholar]
  • Ramachandran D; Ramakrishna VS; Bharath P; Jogarao YS. Development & Validation of RP-HPLC Method for Quantitative Estimation of Dasatinib and its Impurities in Pharmaceutical Dosage Form. J. of Pharm. Res. Int. 2022, 148-155. [Google Scholar]
  • Dumbre NG; Chopade VV; Chaudhari PD. Low-Level Quantification of Potential Genotoxic Impurity In Daclatasvir Hydrochloride By RP-HPLC Method. J. of Pharm. Negative Results. 2022, 13, 1956-1960 [Google Scholar]
  • Abd El-Hay SS; Elhenawee M; Maged K; Ibrahim AE. Cost-effective, green HPLC determination of losartan, valsartan and their nitroso diethylamine impurity: Application to pharmaceutical dosage forms. Royal Society Open Sci. 2022 9, 220-250. [Google Scholar]
  • Al-Rifai N; Alshishani A; Saad B; Rasras A; Darras F. Synthesis, Isolation, Identification and Characterization of a Drug-Excipient Interaction Degradation Impurity in Pramipexole by HPLC, LC/MS and NMR. Separations. 2023, 10, 7. [Google Scholar]
  • Ibrahim AE; El Deeb S; Abdellatef HE; Hendawy HA; Ibrahim H. Eco-friendly and sensitive HPLC and TLC methods validated for the determination of betahistine in the presence of its process-related impurity. Separations. 2022, 9, 1-11. [Google Scholar]
  • Rental C; Gaus H; Bradley K, Luu N; Kolkey K, Mai B. Assay, purity, and impurity profile of phosphorothioate oligonucleotide therapeutics by ion pair–HPLC–MS. Nucleic acid therapeutics. 2022, 3, 206-20. [Google Scholar]
  • Kátia Roberta A; Belaz; Quezia B. Determination of albendazole metabolites by direct injection of bovine plasma and multidimensional achiral-chiral high-performance chromatography. Talanta, 2008, 76, 146-153, [CrossRef] [PubMed] [Google Scholar]
  • Mahrous M; Mabrouk M; Habib A; Draz M. Validated HPLC method for assay of Xipamide, Triamterene and toxic impurity; Benzyl cyanide based on analytical Eco-scale assessment. Delta Univ. Sci. J. 2022, 5, 242-52. [Google Scholar]
  • Chew YL; Hon-Kent K; Mei-Ann L; Kai-Bin B; Lokesh AG. Forced degradation of flibanserin bulk drug: Development and validation of stability indicating RP-HPLC method. Indian J. Pharm. Educ. Res. 2022, 56, 32-42. [CrossRef] [Google Scholar]
  • Council I, Requirements T, Use H. ICH Q3B (R2) Impurities in New Drug Products (ICH/v02062006). ICH Qual Guidel. 2006;(June). [Google Scholar]
  • Divya K; Parameswari Akshinthala; Naresh K, Leela P; Kowtharapu, Naresh K; Rambabu G. ACS Omega 2022 7, 47650-47661 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.